TRV GP IV, LLC — Q4 2024 13F-HR

← TRV GP IV, LLC

Q4 2024 · 13F-HR

TRV GP IV, LLCholdings as filed

Filed 2025-02-13 · accession 0000950123-25-002038

$80.2M

Reported value

Positions

2024-12-31

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
87583X109	TNGX	TANGO THERAPEUTICS, INC.	$52.1M	65.0%	16,859,075	Common	SOLE
729139105	PLRX	PLIANT THERAPEUTICS, INC.	$28.1M	35.0%	2,132,867	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.